Radiation therapy combined with Photofrin or 5-ALA: Effect on Lewis sarcoma tumor lines implanted in mice. Preliminary results

Tumori

Volumn 88, Issue 5, 2002, Pages 407-410

  Schaffer, Moshe ^a   Schaffer, Pamela M ^a   Jori, Giulio ^a   Corti, Luigi ^a   Sotti, Guido ^a   Hofstetter, Alfons ^a   Dühmke, Eckhart ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 ALA; Ionizing irradiation; Photofrin; Photosensitizer; Porphyrins; Radiation therapy; Radiosensitizer

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; RADIOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CHEMICAL MODIFICATION; CONTROLLED STUDY; IONIZING RADIATION; LEWIS CARCINOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; TISSUE REACTION; TUMOR CELL LINE; TUMOR VOLUME;

EID: 0036757523     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800511     Document Type: Article

References (17)

1. Wasserman TH, Chapman JD, Coleman CN, Kligerman MM: Chemical modifiers of radiation. In: Principles and Practice of Radiation Oncology, Perez CA, Brady LW (Eds), pp 685-704, Lippincott Raven Publisher, Philadelphia, 1997.
2. MacDonald IJ, Dougerty TJ: Basic principles of photodynamic therapy, J Porphyrins Phtalocyanines, 5: 105-129, 2001.
3. Berg K, Luksien Z, Moan J: Combined treatment of ionizing radiation and photosensitization by 5-ALA induced protoporphyrin IX. Rad Res, 142: 340-346, 1995.
4. Mang TS: Combination studies of hyperthermia induced by Nd-YAG laser to PDT. Lasers Surg Med, 10: 173-178, 1990.
5. Orenstein A, Kostenich G, Roitman Y, Kopolovic Y, Ehrenberg B, Malik Z: A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e-6, Photofrin II and ALA-induced protoporphyrin IX in a carcinoma model. Br J Cancer, 73: 937-944, 1996.
6. Schwartz S, Absolon K, Vermund H: Some relationships of porphyns, X-rays, and tumors. University of Minnesota, Medical Bulletin, 27: 7-13, 1955.
7. Cohen L, Schwarz S: Modification of radiosensitivity by porphyrins II. Transplanted rhabdomyosarcoma in mice. Cancer Res, 26: 1769-1773, 1966.
8. Moan J, Pettersen EO: X-irradiation of human cells in culture in the presence of haematoporphyrin. Int J Radiat Biol Relat Stud Phys Chem Med, 40: 107-109, 1981.
9. Cittadini G, Lanfredini L, Mancini G: Effetti dell'ematoporfirina sulla radiosensibilità in vitro delle cellule tumorali ATPC+. Boll Soc Ital Sper, 45: 1298-1301, 1969.
10. O'Hara J, Douple EB, Abrams MJ, Picker DJ, Giandomenico CM, Vollano J: Potentiation of radiation induced cell kill by synthetic metalloporphyrin. Int J Radiat Oncol Biol Phys, 16: 1049-1052, 1993.
11. Rowinsky EK: Novel radiation sensitizers targeting tissue hypoxia. Oncology, 13 (Suppl 5): 61-70, 1999.
12. Viala J, Vanel D, Meingan P, Lartigau E, Carde P, Renschler M: Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: Preliminary results in brain metastases. Radiology, 212: 755-759, 1999.
13. Carde P, Timmerman R, Mehta MP, Koprowski CD, Ford J, Tishler RB, Miles D, Miller RA, Renschler MF: Multicenter phase Ib/II trial of the radiation enhrancer motexafin gadolinium in patients with brain metastases. J Clin Oncol, 19: 2074-2083, 2001.
14. Bernhard EJ, Mitchel JB, Deen D, Cardel M, Rosenthal DI, Brown JM: Re-evaluating gadolinium (III) texaphyrin as a radiosensitizing agent. Cancer Res, 60: 86-91, 2000.
15. Kostron H, Swartz M, Miller DC, Martuza RL: The interaction of hematoporphyrin derivative, light, and ionizing radiation in rat glioma model. Cancer, 57: 964-970, 1986.
16. Li XT, Hellmann K: Antitumor effect of RA233 alone and combined with radiotherapy. Clin Exp Metastasis, 1: 181-190, 1983.
17. Shaffer M, Schaffer PM, Corti L, Gardiman M, Sotti G, Hofstetter A, Jori G, Dühmke E: Photofrin as a specific radiosensitizing agent for tumors: Studies in comparison to other porphyrins, in an experimental in vivo model. J Photochem Photobiol B: Biology, 66: 157-164, 2002.